MCOV B Stock Overview
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr131.20 |
| 52 Week High | kr188.40 |
| 52 Week Low | kr118.30 |
| Beta | 1.51 |
| 1 Month Change | -2.74% |
| 3 Month Change | -15.57% |
| 1 Year Change | -27.35% |
| 3 Year Change | -43.81% |
| 5 Year Change | 63.39% |
| Change since IPO | 100.31% |
Recent News & Updates
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Recent updates
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting
Apr 20Medicover (STO:MCOV B) Could Easily Take On More Debt
Apr 08Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price
Mar 15Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?
Feb 25Shareholder Returns
| MCOV B | SE Healthcare | SE Market | |
|---|---|---|---|
| 7D | -3.4% | -3.5% | -0.7% |
| 1Y | -27.4% | -7.0% | 8.7% |
Return vs Industry: MCOV B underperformed the Swedish Healthcare industry which returned -5.1% over the past year.
Return vs Market: MCOV B underperformed the Swedish Market which returned 8.1% over the past year.
Price Volatility
| MCOV B volatility | |
|---|---|
| MCOV B Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 4.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: MCOV B's share price has been volatile over the past 3 months.
Volatility Over Time: MCOV B's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 45,316 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| MCOV B fundamental statistics | |
|---|---|
| Market cap | kr19.63b |
| Earnings (TTM) | kr204.96m |
| Revenue (TTM) | kr20.34b |
95.8x
P/E Ratio1.0x
P/S RatioIs MCOV B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCOV B income statement (TTM) | |
|---|---|
| Revenue | €1.75b |
| Cost of Revenue | €1.39b |
| Gross Profit | €359.40m |
| Other Expenses | €341.80m |
| Earnings | €17.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 20.58% |
| Net Profit Margin | 1.01% |
| Debt/Equity Ratio | 106.9% |
How did MCOV B perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield102%
Payout RatioDoes MCOV B pay a reliable dividends?
See MCOV B dividend history and benchmarks| Medicover dividend dates | |
|---|---|
| Ex Dividend Date | Apr 29 2024 |
| Dividend Pay Date | May 06 2024 |
| Days until Ex dividend | 9 days |
| Days until Dividend pay date | 16 days |
Does MCOV B pay a reliable dividends?
See MCOV B dividend history and benchmarks